- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05768620
Active Navigation Training (ANTaging)
November 24, 2023 updated by: Istituto Auxologico Italiano
Active Navigation Training: an Innovative Embodied-based Training System for Spatial Navigation in Aging
Pilot testing and development of an immersive virtual reality system for spatial navigation training in mild cognitive impairment syndrome.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Lombardia
-
Milan, Lombardia, Italy, 20145
- Cosimo Tuena
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- clinical diagnosis of mild cognitive impairment
- absence of severe cognitive deterioration as assessed by the Italian version of the MMSE (Magni et al. 1996)
- age ≥ 60
Exclusion Criteria:
- the presence of acute stroke/transient ischemic attack;
- the presence of other concomitants severe neurological/psychiatric diseases;
- history of traumatic brain injury with loss of consciousness;
- physical/functional deficits that could affect the use of immersive virtual reality;
- severe visual deficiency;
- the presence of recurrent vertigo.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CAVE
10 immersive virtual reality sessions to train spatial memory
|
The training is designed to train spatial navigation and memory and in particular egocentric and allocentric processes
|
|
Active Comparator: TAU
10 paper and pencil sessions to train spatial memory
|
This is the usual care used to train visuospatial processes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Corsi supra-span test
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
Scores range from 0 to 29.16, higher scores indicate better visuospatial learning
|
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
|
Change in Manikin Test
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
Scores range from 0 to 1, higher scores indicate better visuospatial mental rotation
|
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Trail-making test part A and B
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
|
Raccontino (6 Dicembre) (immediate-delayed-forgetting)
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
|
Mini-mental state examination
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
|
Digit span forward
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
|
Corsi Block Tapping
Time Frame: After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
After 10 training sessions (3/4 weeks approx.) and after 3-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2020
Primary Completion (Actual)
April 1, 2023
Study Completion (Actual)
July 1, 2023
Study Registration Dates
First Submitted
February 22, 2023
First Submitted That Met QC Criteria
March 3, 2023
First Posted (Actual)
March 14, 2023
Study Record Updates
Last Update Posted (Actual)
November 27, 2023
Last Update Submitted That Met QC Criteria
November 24, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 39M801
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
Saglik Bilimleri UniversitesiAnkara UniversityRecruitingAmnestic Mild Cognitive Impairment | Amnestic Mild Cognitive DisorderTurkey
-
Masaryk UniversityRecruitingMild Cognitive Impairment (MCI) Amnestic | Lewy Body Disease With Mild Cognitive Impairment | Parkinson's Disease With Mild Cognitive ImpairmentCzechia
-
High Point UniversityWake Forest University Health Sciences; Hebrew SeniorLifeRecruitingMild Cognitive Impairment (MCI)United States
-
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...Dr. Schär AG / SPARecruitingMild Cognitive Impairment (MCI)Italy
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Çankırı Karatekin UniversityCompletedMild Cognitive Impairment (MCI)Turkey (Türkiye)
-
University of AlbertaCompleted
-
Friedhelm HummelThe Novartis Foundation; Wyss Center for Bio and Neuroengineering; Clinique Romande... and other collaboratorsCompletedMild Cognitive Impairment (MCI)Switzerland
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)TerminatedAmnestic Mild Cognitive ImpairmentUnited States
Clinical Trials on CAVE
-
Augmented eXperience E-health LaboratoryDepartment of Science and Technology (DOST) - Philippine Council for Health...Not yet recruitingParkinson Disease | Parkinson's Disease (PD)Philippines
-
Charite University, Berlin, GermanyCompleted
-
Augmented eXperience E-health LaboratoryActive, not recruiting
-
Pôle Saint HélierINSA RennesCompletedBrain Injuries | Neurologic Disorder | NeurodegenerationFrance
-
The University of Hong KongCompletedChronic Obstructive Pulmonary Disease | Pulmonary Tuberculosis | Community Health Nursing EducationHong Kong